Trademark: 79190252
Status Date
Monday, February 19, 2024
Registration Number
5116707
Registration Date
Tuesday, January 10, 2017
Filing Date
Monday, May 23, 2016
Published for Opposition
Tuesday, October 25, 2016
Cancellation Date
Monday, February 19, 2024
5 [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; ] pharmaceutical preparations for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
The mark consists of two overlapping quadrilaterals in lilac positioned above a blue quadrilateral.
The color(s) lilac and blue is/are claimed as a feature of the mark.
Feb 20, 2024
Notice Of Cancellation Sec. 71 E-Mailed
Feb 19, 2024
Cancelled Section 71
Jul 29, 2023
Post Registration Action Mailed - Sec.71
Jul 21, 2023
Case Assigned To Post Registration Paralegal
Jan 10, 2023
Teas Section 71 Received
Jan 10, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
May 5, 2017
Final Decision Transaction Processed By Ib
Apr 14, 2017
Final Disposition Notice Sent To Ib
Apr 14, 2017
Final Disposition Processed
Apr 10, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jan 10, 2017
Registered-Principal Register
Oct 25, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2016
Published For Opposition
Oct 5, 2016
Notification Of Notice Of Publication E-Mailed
Sep 23, 2016
Refusal Processed By Ib
Sep 21, 2016
Approved For Pub - Principal Register
Sep 20, 2016
Teas/Email Correspondence Entered
Sep 19, 2016
Correspondence Received In Law Office
Sep 19, 2016
Teas Response To Office Action Received
Sep 15, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Sep 8, 2016
Refusal Processed By Mpu
Sep 8, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Sep 7, 2016
Non-Final Action Written
Sep 6, 2016
Assigned To Examiner
Aug 23, 2016
Application Filing Receipt Mailed
Aug 19, 2016
New Application Office Supplied Data Entered
Aug 18, 2016
Limitation From Original Application Entered
Aug 18, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
